Australia may be manufacturing mRNA vaccines for Covid-19 and
other diseases by 2024 under an in-principle agreement struck with pharmaceutical giant Moderna.
Australia to manufacture mRNA vaccines under deal with Moderna | Australia news | The Guardian
Other rare diseases and RNA therapeutics are part of that large Moderna investment and infrastructure to be build in OZ, oncology targeted as well.
This bodes really well for PYC in particular, see Rosenblatts involvement in Moderna.
From his appointment ann earlier in the year:
He also brings expertise in the development of RNA therapeutics through his current role as a member of Moderna Therapeutics’ Development Committee of the Board and Vaccine Acceleration Committee, and as a consultant to Moderna’s Chief Medical Officer.
Was management stepping away from engaging early with US based investors and partners, already knowing that the US would majorly invest in mRNA and RNA therapeutic infrastructure through Moderna down the track in Autralia?
Potentially, this is big news for a mRNA and RNA therapeutic hub in Australia and should, beside concrete financial
outtlook, also raise awareness within the Australian investment community about our role in the RNA therapeutic space.
It is little surprising to have a large OZ based biotech fund buying up stock at discount levels currently.
all IMO
(20min delay)